Patented products
Patents are a prerequisite to preserving Iconovo’s position as an established player for inhalation products. New concepts and methods are continuously patented. The company has designed or is in the process of designing five (5) different inhaler platforms that are protected by seventeen (17) patent families.
The table lists the approved patents. These patents have also been filed internationally.
| Platform | Approved in | Pending | Year of expiry |
|---|---|---|---|
| 1 ICOres® | EP,JP | 2035 | |
| 2 ICOres® | EP | China | 2035 |
| 4 ICOres® | US, JP, IN | 2036/2037 | |
| 5 ICOres® | EP, US | 2036/2037 | |
| 6 ICOres® | EP, CA | 2038 | |
| 7 ICOres® | China | US, IN | 2040 |
| 8 ICOpre® | EP, US | EP, US, JP, IN | 2042 |
| 9 ICOpre® | EP, US | EP, US, China | 2042 |
| 10 ICOone® | EP, US, JP, IN, China | 2036/2037 | |
| 11 ICOone® | EP, US, JP, IN | China | 2038 |
| 12 ICOone Nasal® | EP, US, JP | 2042 | |
| 13 ICOone Nasal® | PCT | 2044 | |
| 14 ICOone Nasal® | PCT | 2044 | |
| 15 ICOone Nasal® | PCT | 2044 | |
| 16 ICOcap® | EP | 2036 | |
| 17 New device | EP, US | 2042 | |
| 18 Inhaled GLP-1 | SE | 2045 |
Possessing a unique combination
of engineering and pharma expertise, Iconovo can provide the optimal combination of customized inhalers and tailored formulations.
ICONOVO AB
VISITING ADDRESS
Ideon, Delta 6 Lund
Ideongatan 3B
POSTAL ADDRESS
Iconovo AB
Ideongatan 3A-B
SE-223 70 LUND
Sweden
CONTACT
Phone: +46 46 275 67 77
Director Business Development and Alliances
Måns Österberg
Mail: mans.osterberg@iconovo.se
CEO
Johan Wäborg
Mail: johan.waborg@iconovo.se
Press releases
Follow us on Linkedin
